MedPath

Eskata

These highlights do not include all the information needed to use ESKATA safely and effectively. See full prescribing information for ESKATA. ESKATA (hydrogen peroxide) topical solution Initial U.S. Approval: 2017

Approved
Approval ID

52f4cc49-6553-426f-9778-0bd34e31b942

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 27, 2019

Manufacturers
FDA

Aclaris Therapeutics, Inc.

DUNS: 032365882

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

hydrogen peroxide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71180-001
Application NumberNDA209305
Product Classification
M
Marketing Category
C73594
G
Generic Name
hydrogen peroxide
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 27, 2019
FDA Product Classification

INGREDIENTS (3)

HYDROGEN PEROXIDEActive
Quantity: 40 mg in 100 mg
Code: BBX060AN9V
Classification: ACTIB
ISOPROPYL ALCOHOLInactive
Code: ND2M416302
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

hydrogen peroxide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71180-002
Application NumberNDA209305
Product Classification
M
Marketing Category
C73594
G
Generic Name
hydrogen peroxide
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 27, 2019
FDA Product Classification

INGREDIENTS (3)

ISOPROPYL ALCOHOLInactive
Code: ND2M416302
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROGEN PEROXIDEActive
Quantity: 40 mg in 100 mg
Code: BBX060AN9V
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Eskata - FDA Drug Approval Details